Ron,
Nice post, but I also think (and have said) that Whelan and Noel were piss poor at managing expectations-- they put out all kinds of teasers the last six months about FDA approval coming "soon" in August/Sept., the audit "nearly done" in December, etc.
While I agree with nearly all your points about pinks, and that the company's product is strong, it all comes down to management's execution for me:
"why not have the audit done completely in December 09, why not try to uplist sooner, why not take the bull by the horns in those areas over which you have some control (obviously, not FDA)...
Given management's track record, how easy was it for the MMs to play their games? Very easy!
So here we sit, waiting for the next episode of what has become a soap opera...
Thanks again!